MARKET

MNMD

MNMD

Mind Medicine
NASDAQ
6.54
-0.24
-3.54%
Opening 11:38 03/26 EDT
OPEN
6.78
PREV CLOSE
6.78
HIGH
6.83
LOW
6.54
VOLUME
320.78K
TURNOVER
--
52 WEEK HIGH
12.22
52 WEEK LOW
5.03
MARKET CAP
492.91M
P/E (TTM)
-4.2401
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MNMD last week (0317-0321)?
Weekly Report · 2d ago
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
TipRanks · 5d ago
Largest borrow rate increases among liquid names
TipRanks · 5d ago
Psychedelic: atai Life Sciences, NRx report quarterly results
TipRanks · 6d ago
MINDMED APPOINTS MATT WILEY AS CHIEF COMMERCIAL OFFICER
Reuters · 03/17 11:00
Weekly Report: what happened at MNMD last week (0310-0314)?
Weekly Report · 03/17 10:52
'Nevada Senators Take Up Resolution Calling On Congress To Reschedule Psychedelics And Streamline Research' - Marijuana Moment
Benzinga · 03/12 15:45
Weekly Report: what happened at MNMD last week (0303-0307)?
Weekly Report · 03/10 10:53
More
About MNMD
Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

Webull offers Mind Medicine (MindMed) Inc stock information, including NASDAQ: MNMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MNMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MNMD stock methods without spending real money on the virtual paper trading platform.